Journal
CHEMISTRY & BIOLOGY
Volume 21, Issue 4, Pages 481-487Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2014.02.009
Keywords
-
Categories
Funding
- Australian Research Council (ARC) [DP110100660]
- National Health and Medical Research Council (Australia) [1021479]
- ARC [FT0990287]
Ask authors/readers for more resources
Evidence suggests that some nonsteroidal anti-inflammatory drugs (NSAIDs) possess antibacterial properties with an unknown mechanism. We describe the in vitro antibacterial properties of the NSAIDs carprofen, bromfenac, and vedaprofen, and show that these NSAIDs inhibit the Escherichia coli DNA polymerase III beta subunit, an essential interaction hub that acts as a mobile tether on DNA for many essential partner proteins in DNA replication and repair. Crystal structures show that the three NSAIDs bind to the sliding clamp at a common binding site required for partner binding. Inhibition of interaction of the clamp loader and/or the replicative polymerase alpha subunit with the sliding clamp is demonstrated using an in vitro DNA replication assay. NSAIDs thus present promising lead scaffolds for novel antibacterial agents targeting the sliding clamp.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available